NCT03249675

Brief Summary

Concussion is widely recognized as a major public health concern in the United States and worldwide. Although many concussions resolve completely and spontaneously, almost 1 in 4 patients will go on to experience post-concussion syndrome (PCS). In the United States, PCS diagnoses have increased 100% from 2010-2015. Concurrently, recent advances in EEG evoked response potential analysis have led to a novel technique for assessing brain network activation (BNA) patterns. The purpose of this study is to explore the use of BNA in individuals who are diagnosed with PCS or have the risk of experiencing PCS due to a recent injury.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jul 2017

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 5, 2017

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

August 8, 2017

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 15, 2017

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2019

Completed
Last Updated

September 28, 2018

Status Verified

September 1, 2018

Enrollment Period

1.5 years

First QC Date

August 8, 2017

Last Update Submit

September 26, 2018

Conditions

Keywords

mild Traumatic Brain InjuryConcussion

Outcome Measures

Primary Outcomes (1)

  • Developing a BNA database for concuss population.

    Functional networks of brain activity in healthy individuals measured using analysis of EEG Event Related Potential (ERP) data

    This study duration is 18 months

Study Arms (2)

ARM 1

ARM 1: Retrospective Arm: Subjects tested with BNA in the past and have been diagnosed by their physician as having Post Concussive Syndrome. Study staff will contact the subjects and obtain Informed Consent. Study physicians will then review both BNA data and Clinical data. All relevant clinical data and all available BNA data will be shared with ElMindA. Subjects may be invited for an additional BNA follow up as part of the study.

ARM 2

ARM 2: Subjects will be prospectively enrolled in the study at the following time points when available: * Acute: within 2 weeks of injury * PCS: Subjects which sustained a concussion in the past 3 months or more, and are still experiencing symptoms related to the injury

Eligibility Criteria

Age12 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Adolescents, young adults and adults of both genders.

You may qualify if:

  • Males and females Aged 12-50
  • Willingness to participate in the study and the ability to give informed assent (for children) and/or consent (for the parent of a minor or adults aged 18 years of age or older for themselves).
  • Subjects that are or were diagnosed with mTBI according to the standard diagnostic procedures at the investigational site in a timeframe that meets enrollment criteria.
  • Subjects that are experiencing symptoms of concussion or Post-concussion Syndrome at the time of their initial test session.

You may not qualify if:

  • Subjects that have undergone neuroimaging with identification of intracranial structural pathology.
  • Self-reported history of central nervous system injury other than mTBI, or disease (examples will include, but will not be limited to, moderate or severe traumatic brain injury (TBI with a Glasgow Coma Scale \< 13) epilepsy, seizures, brain surgery)
  • Neuropsychological disorder such as autistic spectrum disorder
  • Any history of a learning disability (examples include, but will not be limited to, dyslexia, dysgraphia, dyscalculia, or a nonverbal learning disorder)
  • Use of any medication affecting central nervous system (CNS) in the past 3 months prior to their BNA (i.e. antidepressants, anticonvulsants, psychostimulants, first generation antihistamines, etc.)
  • Active head lice infection
  • Open scalp wound
  • baldness, dread locks or hair that is otherwise sufficiently long and thick so as to preclude appropriate scalp electrode cap fit
  • Deafness, and/or blindness

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Sports Neurology Clinic at The CORE Institute

Brighton, Michigan, 48114, United States

Location

MeSH Terms

Conditions

Brain Concussion

Condition Hierarchy (Ancestors)

Brain Injuries, TraumaticBrain InjuriesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemHead Injuries, ClosedWounds and InjuriesWounds, Nonpenetrating

Study Officials

  • Jeffrey Kutcher, MD

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 8, 2017

First Posted

August 15, 2017

Study Start

July 5, 2017

Primary Completion

January 1, 2019

Study Completion

January 1, 2019

Last Updated

September 28, 2018

Record last verified: 2018-09

Locations